Spectral AI Announces Annual Meeting of Stockholders
Rhea-AI Summary
Spectral AI (Nasdaq: MDAI) will hold its 2026 Annual Meeting of Stockholders at 9:30 a.m. CDT on Friday, May 29, 2026. Only holders of record at the close of business on April 1, 2026 may vote.
Stockholders may attend in person at the company headquarters or join virtually by registering in advance at www.proxydocs.com/MDAI using the 12- or 16-digit control number. The company filed a Definitive Proxy Statement on April 16, 2026; a free copy is available at www.sec.gov or via Spectral AI's investor site.
Positive
- None.
Negative
- None.
News Market Reaction – MDAI
In the Apr 21 session, MDAI declined 5.29%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous AI Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 09 | Conference presence | Positive | -0.6% | DeepView® System featured at American Burn Association Annual Meeting. |
| Apr 08 | Executive appointment | Positive | +2.4% | Appointment of new CFO to support commercialization efforts. |
| Mar 18 | Non-dilutive funding | Positive | +18.3% | BARDA awarded $31.7M to accelerate DeepView® System development. |
| Feb 10 | CEO transition | Positive | +0.7% | Promotion of Vincent S. Capone to CEO supporting commercialization. |
| Feb 02 | Awareness campaign | Positive | -2.9% | Participation in National Burn Awareness Week with ABA partnership. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-tagged news has often been positive in tone, with three out of five past events seeing price gains, but there are also instances where favorable visibility events coincided with modest declines.
Over recent months, Spectral AI’s AI-tagged news has centered on leadership changes, non-dilutive BARDA funding, and awareness or conference activities supporting the DeepView® burn assessment platform. Events such as the $31.7M BARDA award on Mar 18, 2026 and executive appointments have drawn mixed price reactions, combining notable rallies with modest pullbacks. Today’s annual meeting announcement fits within this governance and corporate housekeeping stream rather than a product or funding milestone.
Key Terms
record date regulatory
definitive proxy statement regulatory
proxy card regulatory
voting instruction form regulatory
securities and exchange commission regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
DALLAS, April 20, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that its 2026 Annual Meeting of Stockholders (“Annual Meeting”) will take place at 9:30 a.m. Central Daylight Time on Friday, May 29, 2026.
Only stockholders of record at the close of business on April 1, 2026, the record date, will be entitled to vote at the Annual Meeting.
To be admitted to the Annual Meeting, stockholders as of the record date can either attend in person at the Company’s corporate headquarters or virtually by registering in advance using the following link: www.proxydocs.com/MDAI and entering the 12 or 16-digit control number found on the notice, proxy card or the voting instruction form. By logging onto the website, stockholders as of the record date will be able to vote shares electronically on all items to be considered at the Annual Meeting.
Important information about the Annual Meeting and the matters to be considered are available in the Definitive Proxy Statement filed by Spectral AI with the United States Securities and Exchange Commission on April 16, 2026. A copy of the Definitive Proxy Statement is available free of charge at www.sec.gov or the via the Investor Relations section of Spectral AI’s website at https://investors.spectral-ai.com/.
About Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView System. The DeepView System is being developed as a predictive diagnostic device to offer clinicians an objective and immediate assessment of a burn wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, the DeepView System is expected to provide fast and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. Spectral AI has been named to TIME’s list of World’s Top HealthTech companies 2025. For more information about the DeepView System, visit www.spectral-ai.com.
Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing factors, and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the US Securities and Exchange Commission, including the Company’s Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
| Investors: | |
| The Equity Group | |
| Devin Sullivan | Conor Rodriguez |
| Managing Director | Associate |
| dsullivan@theequitygroup.com | crodriguez@theequitygroup.com |
